• Avidity Biosciences Reports Third Quarter 2020 Financial Results and Recent Highlights

    18 days ago - By San Diego Biotechnology

    LA JOLLA, Calif., Nov. 10, 2020 /PRNewswire/ - Avidity Biosciences, Inc. , a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates , today repo......
    Read more ...